Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
The nonprofit group gives $20,000 grants to rare disease researchers every year. One scientist who received the award in 2022…
EURORDIS, which represents rare disease patients in Europe, celebrates advocates who distinguish themselves in categories inc…
A new survey of more than 1,000 U.S. residents finds that few know how common rare diseases are, but 85% said it was importan…
Few Australians understand how common rare diseases are, but 89% said it was important to research innovative new treatments,…
This February 29, we bring our collective focus to the cause and demonstrate the power of showing our stripes, says therapist…
Dr. Brittany Clayborne travels the United States inspiring others to share their story. Here are the tips she offered at the …
With pro football fanfare, Uplifting Athletes will celebrate early career scientists later this week by awarding $20,000 gran…
Eurordis, the European patient advocacy group, invites people around the world to take a photo that “visually expresses what …
Patient organizations have until February 18 to apply for CSL Behring’s Local Empowerment for Advocacy Development (LEAD) Gra…
The global celebration unites rare disease patients and their advocates on February 29. Find out how to show your support.
The National Organization for Rare Disorders (NORD) recently launched new informational resources on genetic testing, which c…
The University of Pennsylvania’s Dr. Jim Wilson turned his love of cycling into an annual event that has channeled $17 millio…
Americas
Asia Pacific
Middle East
Europe